Covid-19 roundup: Moderna posts $1.1B in Covid-19 vaccine deposits; Gilead CEO sees potential need for Veklury on a 'seasonal basis'

Moderna’s $MRNA executive team is clearly itching to get a near-term EUA for their Covid-19 vaccine.

The mRNA wunderkind posted an update on their pivotal …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Mod­er­na posts $1.1B in Covid-19 vac­cine de­posits; Gilead CEO sees po­ten­tial need for Vek­lury on a 'sea­son­al ba­sis'